NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Influence of Social Determinants of Health on the Management of HCC in the French National Cohort Study CHIEF
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Pressure-enabled Delivery in Radioembolization (TriNav Study)
- Status
- COMPLETED
- Phase
- NA
The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study
- Status
- COMPLETED
- Phase
- NA
BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Effect and Safety of Recombinant Human Adenovirus Type 5 in Advanced HCC With Stable Disease After Sorafenib Treatment
- Status
- UNKNOWN
- Phase
- PHASE4
Neoadjuvant and Adjuvant Lenvatinib in HCC Patients Treated by Percutaneous Ablative
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Holmium-166 Retrospective Collection of Real-World Data
- Status
- COMPLETED
- Phase
- N/A
TQB2450 Plus Anlotinib as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Resection
- Status
- UNKNOWN
- Phase
- PHASE2
Comparison of Hepatic Intraarterial Versus Systemic Intravenous 68Ga-PSMA PET/CT for Detection of Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Predictive Power of Share Wave Fibro Scan in HCC After HCV Infection
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of Autoimmune Cell Therapy for Patients With Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)
- Status
- COMPLETED
- Phase
- PHASE2
PVE/PVL Combined With DEB-TACE in the Treatment of Patients With Large and Unresectable Liver Cancer
- Status
- RECRUITING
- Phase
- NA
Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.
- Status
- RECRUITING
- Phase
- NA
Hepatocellular Carcinoma Imaging Using PSMA PET/CT
- Status
- COMPLETED
- Phase
- PHASE2
Role of DEB-TACE Versus c-TACE in Treatment of HCC
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1